Ack1: Activation and Regulation by Allostery

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Gajiwala, Ketan S ^a   Maegley, Karen ^a   Ferre, RoseAnn ^a   He, You Ai ^a   Yu, Xiu ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CDC42 ASSOCIATED KINASE; PROTEIN SH3; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ALLOSTERISM; AMINO TERMINAL SEQUENCE; ARTICLE; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; MOLECULAR CLONING; MOLECULAR MECHANICS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

ALLOSTERIC REGULATION; ANIMALS; CRYSTALLOGRAPHY, X-RAY; ENZYME ACTIVATION; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN-TYROSINE KINASES; SF9 CELLS; SPODOPTERA;

EID: 84872286255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053994     Document Type: Article

References (34)

1. Blume-Jensen P, Hunter T, (2001) Oncogenic kinase signalling. Nature 411: 355-365.
2. Sicheri F, Moarefi I, Kuriyan J, (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature 385: 602-609.
3. Sicheri F, Kuriyan J, (1997) Structures of Src-family tyrosine kinases. Curr Opin Struct Biol 7: 777-785.
4. Xu W, Harrison SC, Eck MJ, (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385: 595-602.
5. Nagar B, Hantschel O, Young MA, Scheffzek K, Veach D, et al. (2003) Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112: 859-871.
6. Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, et al. (1997) Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385: 650-653.
7. Prieto-Echague V, Miller WT, (2011) Regulation of ack-family nonreceptor tyrosine kinases. J Signal Transduct 2011: 742372.
8. Manser E, Leung T, Salihuddin H, Tan L, Lim L, (1993) A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature 363: 364-367.
9. Galisteo ML, Yang Y, Urena J, Schlessinger J, (2006) Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli. Proc Natl Acad Sci U S A 103: 9796-9801.
10. Chan W, Sit ST, Manser E, (2011) The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation. Biochem J 435: 355-364.
11. Eisenmann KM, McCarthy JB, Simpson MA, Keely PJ, Guan JL, et al. (1999) Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol 1: 507-513.
12. Yeow-Fong L, Lim L, Manser E, (2005) SNX9 as an adaptor for linking synaptojanin-1 to the Cdc42 effector ACK1. FEBS Lett 579: 5040-5048.
13. Yokoyama N, Lougheed J, Miller WT, (2005) Phosphorylation of WASP by the Cdc42-associated kinase ACK1: dual hydroxyamino acid specificity in a tyrosine kinase. J Biol Chem 280: 42219-42226.
14. van der Horst EH, Degenhardt YY, Strelow A, Slavin A, Chinn L, et al. (2005) Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc Natl Acad Sci U S A 102: 15901-15906.
15. Mahajan NP, Whang YE, Mohler JL, Earp HS, (2005) Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res 65: 10514-10523.
16. Mahajan NP, Liu Y, Majumder S, Warren MR, Parker CE, et al. (2007) Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc Natl Acad Sci U S A 104: 8438-8443.
17. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
18. Yokoyama N, Miller WT, (2003) Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. Substrate specificity, authphosphorylation, and interaction with Hck. J Biol Chem 278: 47713-47723.
19. Lougheed JC, Chen RH, Mak P, Stout TJ, (2004) Crystal structures of the phosphorylated and unphosphorylated kinase domains of the Cdc42-associated tyrosine kinase ACK1. J Biol Chem 279: 44039-44045.
20. Prieto-Echague V, Gucwa A, Brown DA, Miller WT, (2010) Regulation of Ack1 localization and activity by the amino-terminal SAM domain. BMC Biochem 11: 42.
21. Kopecky DJ, Hao X, Chen Y, Fu J, Jiao X, et al. (2008) Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors. Bioorg Med Chem Lett 18: 6352-6356.
22. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J, (2006) An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125: 1137-1149.
23. Armstrong RN, (1997) Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 10: 2-18.
24. Terpe K, (2003) Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 60: 523-533.
25. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, et al. (1995) Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376: 313-320.
26. Musacchio A, Noble M, Pauptit R, Wierenga R, Saraste M, (1992) Crystal structure of a Src-homology 3 (SH3) domain. Nature 359: 851-855.
27. Zhang X, Pickin KA, Bose R, Jura N, Cole PA, et al. (2007) Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450: 741-744.
28. Lim WA, Richards FM, Fox RO, (1994) Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature 372: 375-379.
29. Massenet C, Chenavas S, Cohen-Addad C, Dagher MC, Brandolin G, et al. (2005) Effects of p47phox C terminus phosphorylations on binding interactions with p40phox and p67phox. Structural and functional comparison of p40phox and p67phox SH3 domains. J Biol Chem 280: 13752-13761.
30. Kristensen O, Guenat S, Dar I, Allaman-Pillet N, Abderrahmani A, et al. (2006) A unique set of SH3-SH3 interactions controls IB1 homodimerization. EMBO J 25: 785-797.
31. Endres NF, Engel K, Das R, Kovacs E, Kuriyan J (2011) Regulation of the catalytic activity of the EGF receptor. Curr Opin Struct Biol.
32. Jura N, Endres NF, Engel K, Deindl S, Das R, et al. (2009) Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137: 1293-1307.
33. Thiel KW, Carpenter G, (2007) Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation. Proc Natl Acad Sci U S A 104: 19238-19243.
34. Shindyalov IN, Bourne PE, (1998) Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Protein Eng 11: 739-747.